| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| Gesamt | 723.718.198 $ | +90.453.706 $ | +24,9 % | 52 | 653.863.097 $ | -50.499.325 $ | -1,6 % | 51 | 718.352.025 $ | +197.484.923 $ | +24,1 % | 49 | |||
| INSMED Inc | INSM | → 0 | Schwach | 44.138.548 $ | -23.766.239 $ | -35,0 % | 1 | 67.904.787 $ | -17.284.660 $ | -20,3 % | 1 | 85.189.447 $ | +14.364.609 $ | +20,3 % | 1 |
| PTC THERAPEUTICS, INC. | PTCT | → 0 | Sehr stark | 74.950.268 $ | +12.161.183 $ | +19,4 % | 1 | 62.789.085 $ | -5.872.374 $ | -8,6 % | 1 | 68.661.459 $ | +15.722.899 $ | +29,7 % | 1 |
| AMICUS THERAPEUTICS, INC. | FOLD | → 0 | 16.094.631 $ | -58.035.491 $ | -78,3 % | 1 | 74.130.122 $ | +31.831.874 $ | +75,3 % | 1 | |||||
| ACADIA PHARMACEUTICALS INC | ACAD | → 0 | Neutral | 72.461.629 $ | +8.515.438 $ | +13,3 % | 1 | 63.946.191 $ | -2.402.277 $ | -3,6 % | 1 | 66.348.468 $ | +13.709.431 $ | +26,0 % | 1 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | → 0 | Neutral | 39.068.500 $ | +362.569 $ | +0,9 % | 1 | 38.705.931 $ | -5.644.063 $ | -12,7 % | 1 | 44.349.994 $ | +3.512.975 $ | +8,6 % | 1 |
| Mirum Pharmaceuticals, Inc. | MIRM | → 0 | Neutral | 40.834.953 $ | +10.795.286 $ | +35,9 % | 1 | 30.039.667 $ | +17.683.972 $ | +143,1 % | 1 | 12.355.695 $ | +7.612.538 $ | +160,5 % | 1 |
| ANAPTYSBIO, INC | ANAB | → 0 | Neutral | 40.735.508 $ | +5.343.099 $ | +15,1 % | 1 | 35.392.409 $ | +1.939.658 $ | +5,8 % | 1 | 33.452.751 $ | +12.829.569 $ | +62,2 % | 1 |
| UNITED THERAPEUTICS Corp | UTHR | → 0 | Neutral | 33.911.514 $ | -3.332.967 $ | -8,9 % | 1 | 37.244.481 $ | +8.893.352 $ | +31,4 % | 1 | 28.351.129 $ | +3.958.976 $ | +16,2 % | 1 |
| Dyne Therapeutics, Inc. | DYN | → 0 | Neutral | 36.591.441 $ | +6.623.059 $ | +22,1 % | 1 | 29.968.382 $ | +1.172.209 $ | +4,1 % | 1 | 28.796.173 $ | +12.823.347 $ | +80,3 % | 1 |
| BIOGEN INC. | BIIB | → 0 | Stark | 30.308.681 $ | +4.510.667 $ | +17,5 % | 1 | 25.798.014 $ | -6.508.646 $ | -20,1 % | 1 | 32.306.660 $ | +6.299.267 $ | +24,2 % | 1 |
| Disc Medicine, Inc. | IRON | → 0 | Neutral | 30.473.488 $ | +4.787.575 $ | +18,6 % | 1 | 25.685.913 $ | +476.732 $ | +1,9 % | 1 | 25.209.181 $ | +10.387.437 $ | +70,1 % | 1 |
| IOVANCE BIOTHERAPEUTICS, INC. | IOVA | → 0 | Schwach | 22.032.229 $ | -254.737 $ | -1,1 % | 1 | 22.286.966 $ | +2.858.441 $ | +14,7 % | 1 | 19.428.525 $ | +2.897.179 $ | +17,5 % | 1 |
| Syndax Pharmaceuticals Inc | SNDX | → 0 | Schwach | 18.908.594 $ | -1.297.479 $ | -6,4 % | 1 | 20.206.073 $ | +3.513.481 $ | +21,0 % | 1 | 16.692.592 $ | +6.616.494 $ | +65,7 % | 1 |
| Ultragenyx Pharmaceutical Inc. | RARE | → 0 | Schwach | 19.916.968 $ | +7.420.398 $ | +59,4 % | 1 | 12.496.570 $ | +1.886.808 $ | +17,8 % | 1 | 10.609.762 $ | -505.730 $ | -4,5 % | 1 |
| NovoCure Ltd | NVCR | → 0 | Schwach | 19.398.651 $ | +5.441.866 $ | +39,0 % | 1 | 13.956.785 $ | -2.838.820 $ | -16,9 % | 1 | 16.795.605 $ | +566.031 $ | +3,5 % | 1 |
| Annexon, Inc. | ANNX | → 0 | Neutral | 16.833.594 $ | +501.175 $ | +3,1 % | 1 | 16.332.419 $ | +4.363.775 $ | +36,5 % | 1 | 11.968.644 $ | +11.968.644 $ | 1 | |
| Bicara Therapeutics Inc. | BCAX | → 0 | Neutral | 16.341.614 $ | +5.393.999 $ | +49,3 % | 1 | 10.947.615 $ | +5.922.598 $ | +117,9 % | 1 | 5.025.017 $ | +5.025.017 $ | 1 | |
| CareDx, Inc. | CDNA | → 0 | Neutral | 15.158.295 $ | +5.925.032 $ | +64,2 % | 1 | 9.233.263 $ | +223.598 $ | +2,5 % | 1 | 9.009.665 $ | +4.412.059 $ | +96,0 % | 1 |
| Celldex Therapeutics, Inc. | CLDX | → 0 | Schwach | 14.878.642 $ | +5.476.580 $ | +58,2 % | 1 | 9.402.062 $ | +9.402.062 $ | 1 | |||||
| Gossamer Bio, Inc. | GOSS | → 0 | Sehr schwach | 13.861.935 $ | -509.303 $ | -3,5 % | 1 | ||||||||
| Compass Therapeutics, Inc. | CMPX | → 0 | Neutral | 12.771.670 $ | +4.759.944 $ | +59,4 % | 1 | 8.011.726 $ | -5.587.364 $ | -41,1 % | 1 | 13.599.090 $ | +13.599.090 $ | 1 | |
| Alkermes plc. | ALKS | → 0 | Sehr stark | 12.708.931 $ | +4.132.009 $ | +48,2 % | 1 | 8.576.922 $ | +1.790.093 $ | +26,4 % | 1 | 6.786.829 $ | +1.268.689 $ | +23,0 % | 1 |
| PROTHENA CORP PUBLIC LTD CO | PRTA | → 0 | Neutral | 11.191.487 $ | -555.794 $ | -4,7 % | 1 | 11.747.281 $ | -863.590 $ | -6,8 % | 1 | 12.610.871 $ | -311.642 $ | -2,4 % | 1 |
| First Tracks Biotherapeutics, Inc. | TRAX | → 0 | Neutral | 12.142.199 $ | +12.142.199 $ | 1 | |||||||||
| Denali Therapeutics Inc. | DNLI | → 0 | Neutral | 4.503.974 $ | -6.082.882 $ | -57,5 % | 1 | 10.586.856 $ | +4.662.609 $ | +78,7 % | 1 | ||||
| Travere Therapeutics, Inc. | TVTX | → 0 | Neutral | 9.517.095 $ | +2.670.336 $ | +39,0 % | 1 | 6.846.759 $ | +2.616.186 $ | +61,8 % | 1 | 4.230.573 $ | +1.584.389 $ | +59,9 % | 1 |
| Taysha Gene Therapies, Inc. | TSHA | → 0 | Neutral | 9.475.311 $ | +3.255.833 $ | +52,3 % | 1 | 6.219.478 $ | -288.095 $ | -4,4 % | 1 | 6.507.573 $ | +2.433.045 $ | +59,7 % | 1 |
| Aclaris Therapeutics, Inc. | ACRS | → 0 | Schwach | 8.535.045 $ | +2.484.682 $ | +41,1 % | 1 | 6.050.363 $ | +1.334.175 $ | +28,3 % | 1 | 4.716.188 $ | +1.739.192 $ | +58,4 % | 1 |
| AGIOS PHARMACEUTICALS, INC. | AGIO | → 0 | Neutral | 7.926.733 $ | +700.611 $ | +9,7 % | 1 | 7.226.122 $ | +1.441.899 $ | +24,9 % | 1 | 5.784.223 $ | -4.872.827 $ | -45,7 % | 1 |
| ALIGN TECHNOLOGY INC | ALGN | → 0 | Neutral | 5.294.069 $ | -1.823.705 $ | -25,6 % | 1 | 7.117.774 $ | +634.426 $ | +9,8 % | 1 | 6.483.348 $ | +756.411 $ | +13,2 % | 1 |
| eHealth, Inc. | EHTH | → 0 | Neutral | 2.209.368 $ | +296.560 $ | +15,5 % | 1 | 1.912.808 $ | -5.131.765 $ | -72,8 % | 1 | 7.044.573 $ | +387.265 $ | +5,8 % | 1 |
| CAPRICOR THERAPEUTICS, INC. | CAPR | → 0 | Sehr schwach | 5.532.693 $ | -1.452.102 $ | -20,8 % | 1 | 6.984.795 $ | +453.662 $ | +6,9 % | 1 | 6.531.133 $ | +6.531.133 $ | 1 | |
| Nuvation Bio Inc. | NUVB | → 0 | Schwach | 1.855.139 $ | -327.810 $ | -15,0 % | 1 | 2.182.949 $ | -2.638.239 $ | -54,7 % | 1 | 4.821.188 $ | +1.045.164 $ | +27,7 % | 1 |
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 3.099.184 $ | +113.472 $ | +3,8 % | 1 | 2.985.712 $ | -1.340.270 $ | -31,0 % | 1 | 4.325.982 $ | +4.325.982 $ | 1 | |
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 3.192.573 $ | +250.309 $ | +8,5 % | 1 | 2.942.264 $ | +1.124.119 $ | +61,8 % | 1 | 1.818.145 $ | +1.026.835 $ | +129,8 % | 1 |
| NEUROCRINE BIOSCIENCES INC | NBIX | → 0 | Stark | 3.053.349 $ | +666.615 $ | +27,9 % | 1 | 2.386.734 $ | -182.800 $ | -7,1 % | 1 | 2.569.534 $ | +26.270 $ | +1,0 % | 1 |
| Edwards Lifesciences Corp | EW | → 0 | Stark | 3.043.074 $ | +349.183 $ | +13,0 % | 1 | 2.693.891 $ | -173.919 $ | -6,1 % | 1 | 2.867.810 $ | +251.627 $ | +9,6 % | 1 |
| Stoke Therapeutics, Inc. | STOK | → 0 | Neutral | 2.769.126 $ | +13.541 $ | +0,5 % | 1 | 2.755.585 $ | +469.607 $ | +20,5 % | 1 | 2.285.978 $ | -191.557 $ | -7,7 % | 1 |
| CYTOKINETICS INC | CYTK | → 0 | Schwach | 2.742.692 $ | +620.720 $ | +29,3 % | 1 | 2.121.972 $ | +2.121.972 $ | 1 | |||||
| Pyxis Oncology, Inc. | PYXS | → 0 | Schwach | 2.601.474 $ | +1.126.129 $ | +76,3 % | 1 | 1.475.345 $ | +282.311 $ | +23,7 % | 1 | 1.193.034 $ | -1.110.041 $ | -48,2 % | 1 |
| CRISPR Therapeutics AG | CRSP | → 0 | Neutral | 2.160.057 $ | +276.047 $ | +14,7 % | 1 | 1.884.010 $ | -277.881 $ | -12,9 % | 1 | 2.161.891 $ | -509.966 $ | -19,1 % | 1 |
| Sagimet Biosciences Inc. | SGMT | → 0 | Neutral | 1.932.500 $ | +1.932.500 $ | 1 | |||||||||
| BioNTech SE | BNTX | → 0 | Stark | 1.825.083 $ | +81.791 $ | +4,7 % | 1 | 1.743.292 $ | -123.961 $ | -6,6 % | 1 | 1.867.253 $ | -67.080 $ | -3,5 % | 1 |
| COMPASS Pathways plc | CMPS | → 0 | Neutral | 1.635.966 $ | +996.610 $ | +155,9 % | 1 | 639.356 $ | -158.394 $ | -19,9 % | 1 | 797.750 $ | +797.750 $ | 1 | |
| HUMANA INC | HUM | → 0 | Neutral | 1.582.922 $ | +891.963 $ | +129,1 % | 1 | 690.959 $ | -329.719 $ | -32,3 % | 1 | 1.020.678 $ | -16.099 $ | -1,6 % | 1 |
| BICYCLE THERAPEUTICS PLC | BCYC | → 0 | Neutral | 856.014 $ | -80.756 $ | -8,6 % | 1 | 936.770 $ | -628.413 $ | -40,1 % | 1 | 1.565.183 $ | -145.907 $ | -8,5 % | 1 |
| NewAmsterdam Pharma Co N.V. | NAMS | → 0 | Schwach | 1.503.327 $ | +1.503.327 $ | 1 | |||||||||
| Verastem, Inc. | VSTM | → 0 | Neutral | 1.182.997 $ | -121.296 $ | -9,3 % | 1 | 1.304.293 $ | +1.304.293 $ | 1 | |||||
| Aldeyra Therapeutics, Inc. | ALDX | → 0 | Neutral | 331.660 $ | +68.512 $ | +26,0 % | 1 | 263.148 $ | -904.761 $ | -77,5 % | 1 | 1.167.909 $ | -9.018 $ | -0,8 % | 1 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | → 0 | Neutral | 959.530 $ | +24.089 $ | +2,6 % | 1 | 935.441 $ | +935.441 $ | 1 | |||||
| UroGen Pharma Ltd. | URGN | → 0 | Schwach | 901.600 $ | +461.090 $ | +104,7 % | 1 | 440.510 $ | -133.280 $ | -23,2 % | 1 | 573.790 $ | +85.015 $ | +17,4 % | 1 |
| Xeris Biopharma Holdings, Inc. | XERS | → 0 | Neutral | 826.927 $ | +221.349 $ | +36,6 % | 1 | 605.578 $ | +605.578 $ | 1 | |||||
| Inspire Medical Systems, Inc. | INSP | → 0 | Stark | 391.319 $ | -61.141 $ | -13,5 % | 1 | 452.460 $ | -356.582 $ | -44,1 % | 1 | 809.042 $ | +809.042 $ | 1 | |
| ABEONA THERAPEUTICS INC. | ABEO | → 0 | Neutral | 672.786 $ | +185.071 $ | +37,9 % | 1 | 487.715 $ | -86.004 $ | -15,0 % | 1 | 573.719 $ | -1.088 $ | -0,2 % | 1 |
| ProQR Therapeutics N.V. | PRQR | → 0 | Neutral | 351.181 $ | +45.314 $ | +14,8 % | 1 | 305.867 $ | -75.523 $ | -19,8 % | 1 | 381.390 $ | -20.769 $ | -5,2 % | 1 |
| Generation Bio Co. | GBIO | → 0 | 85.467 $ | -6.621 $ | -7,2 % | 1 | |||||||||
| Akari Therapeutics Plc | AKTX | → 0 | Neutral | 42.201 $ | -105.283 $ | -71,4 % | 1 | ||||||||
| Gesamt | 723.718.198 $ | +90.453.706 $ | +24,9 % | 52 | 653.863.097 $ | -50.499.325 $ | -1,6 % | 51 | 718.352.025 $ | +197.484.923 $ | +24,1 % | 49 | |||